Aerpio AKB-9778-CI-5001 TIME-2b
Posted by: Georgia Retina in
Research Title: Phase 2 Double-Masked, Placebo-Controlled Study to Assess the Safety and Efficacy of Subcutaneously Administered AKB-9778 15mg Once Daily or 15mg Twice Daily for 12 Months in Patients With Moderate to Severe Non-Proliferative Diabetic Retinopathy Sponsor: Aerpio Therapeutics, LLC Principal Investigator: Sri Krishna Mukkamala, M.D. Description: The purpose of this study is to evaluate the safety and efficacy…
Read More
Allergan 150998-005 CEDAR
Posted by: Georgia Retina in
Research Title: A Safety and Efficacy Study of Abicipar Pegol in Patients With Neovascular Age-Related Macular Degeneration Sponsor: Allergan Principal Investigator: Robert A. Stoltz, M.D., Ph.D. Description: This is a safety and efficacy study of abicipar pegol in patients with neovascular age-related macular degeneration. Start Date: October 2015 Recruitment: Complete Project Personnel: Leslie Marcus, CCRC; Caitlin Harrison, CCRC, COA; Stephanie Campbell, CRC,…
Read More Allergan 190342-038 BEACON
Posted by: Georgia Retina in
Research Title: A Safety and Efficacy Study of Brimonidine Intravitreal Implant in Geographic Atrophy Secondary to Age-related Macular Degeneration. Sponsor: Allergan Principal Investigator: Mark J. Rivellese, M.D. Description: This study will assess the safety and efficacy of the brimonidine intravitreal implant in patients with geographic atrophy due to age-related macular degeneration. Start Date: December 2015 Recruitment: Completed Project Personnel: Leslie Marcus, CCRC;…
Read More AREDS2 ForeseeHome
Posted by: Georgia Retina in
Research Title: Home Vision Monitoring in Age-Related Eye Disease 2 (AREDS2) Using the ForeseeHome Device Sponsor: Notal Vision, Ltd. Principal Investigator: Jay Stallman, M.D. Description: The overall objective of this two arm randomized clinical trial (RCT) is to determine if home monitoring using the comprehensive visual field and telemedicine solution based on the ForeseeHome device in AREDS2 improves detection…
Read More C-09-067 RACE
Posted by: Georgia Retina in
Research Title: Evaluation of AL-78898A in Exudative Age-Related Macular Degeneration (AMD) Sponsor: Alcon Research Principal Investigator: Mark J. Rivellese, MD Description: The primary purpose of the study is to demonstrate a biological effect of AL-78898A after a single intravitreal injection. Start Date: November 2011 Recruitment: Completed Project Personnel: Leslie Marcus, CCRC Location(s): Tucker; 1462 Montreal Road West, Suite 412, Tucker, GA 30084
Read More DRCR.net Protocol N
Posted by: Georgia Retina in
Research Title: An Evaluation of Intravitreal Ranibizumab for Vitreous Hemorrhage Due to Proliferative Diabetic Retinopathy Sponsor: The Diabetic Retinopathy Clinical Research Network Principal Investigator: Robert Stoltz, M.D Ph.D Description: To determine if intravitreal injections of ranibizumab decrease the proportion of eyes in which vitrectomy is performed compared with saline injections in eyes presenting with vitreous hemorrhage from proliferative diabetic…
Read More Gemini GEM-NH-002 Clarity 2
Posted by: Georgia Retina in
Research Title: A Prospective Natural History Study to Evaluate Clinical Characteristics and Disease Progression in Subjects with Non-Central Geographic Atrophy (GA) Who Are Carriers of High-Risk Genetic Variants of Complement Factor H (CFH) Sponsor: Gemini Therapeutics, Inc. Principal Investigator: Robert Stoltz, M.D., Ph.D. Description: This is a prospective, multicenter, natural history (NH) study, conducted in subjects with non-central GA…
Read More Genentech GR39821
Posted by: Georgia Retina in
Research Title: A Phase I, Multicenter, Open-Label, Single-Dose, Dose-Escalation, and Multiple-Dose Study of the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7171009 in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration. Sponsor: Genentech, Inc. Principal Investigator: Robert Stoltz, M.D., Ph.D. Description: This Phase 1, open-label, multicenter study will investigate the safety and tolerability of RO7171009 following…
Read More Graybug GBV-102-002 Altissimo
Posted by: Georgia Retina in
Research Title: A Phase 2b Multicenter Dose-Ranging Study Evaluating the Safety and Efficacy of Sunitinib Malate Depot Formulation (GB-102) Compared to Aflibercept in Subjects With Neovascular (Wet) Age-related Macular Degeneration (ALTISSIMO Study) Sponsor: Graybug Vision Principal Investigator: Atul Sharma, M.D. Description: Phase 2b, multicenter, visual examiner-masked, randomized active-controlled, parallel-arm design study to evaluate the safety and duration of the…
Read More HORIZON FVF3426g
Posted by: Georgia Retina in
Research Title: An Extension Study to Evaluate the Safety and Tolerability of Ranibizumab in Subjects With Choroidal Neovascularization Secondary to AMD or Macular Edema Secondary to RVO Sponsor: Genentech Principal Investigator: Jay Stallman, M.D. Description: This is an open-label, multicenter, extension study of intravitreally administered ranibizumab in subjects with primary or recurrent CNV secondary to AMD who have completed…
Read More 
